Lessons learned in applying the U.S. EPA proposed cancer guidelines to specific compounds

Toxicological Sciences

Volumn 53, Issue 2, 2000, Pages 159-172

  Andersen, Melvin E ^a   Meek, M Elizabeth ^c   Boorman, Gary A ^c   Brusick, David J ^c   Cohen, Samuel M ^c   Dragan, Yvonne P ^c   Frederick, Clay B ^c   Goodman, Jay I ^c   Hard, Gordon C ^c   O'Flaherty, Ellen J ^c   Robinson, Denise E ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

^c NONE

Author keywords

Chloroform; Dichloroacetic acid; Evidence, preponderance of; Harmonization; Margin of exposure; Mode of action; Modeling, toxicokinetic; Proposed cancer guidelines; Risk assessment; U.S. EPA

Indexed keywords

CARCINOGEN; CHLOROFORM; DICHLOROACETIC ACID;

CANCER RISK; CARCINOGEN TESTING; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL PROTECTION; HUMAN; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; TOXICOKINETICS; UNITED STATES;

EID: 0033956251     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/53.2.159     Document Type: Review

References (86)

1. Ade, P., Guastadisegni, C., Testai, E., and Vittozzi, L. (1994). Multiple activation of chloroform in kidney microsomes from male and female DBA/2J mice. J. Biochem. Toxicol. 9, 289-295.
2. Andersen, M. E., Clewell III, H. J., Gargas, M. L., Smith, F. A., and Reitz, R. H. (1987). Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87, 185-205.
3. Barton H. A., Andersen M. E. and Clewell III, H. J., (1998). Harmonization: Developing consistent guidelines for applying mode of action and dosimetry information to cancer and noncancer risk assessment. Hum. Ecol. Risk Assess. 4, 75-115.
4. Bogdanffy, M. S., Sarangapani, R., Plowchalk, D. R., Jarabek, A., and Andersen, M. E. (1999). A biologically based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity. Toxicol. Sci. 51, 19-35.
5. Borghoff, S. J., Murphy, J. E., and Dix, K. (1994). Validation of a chloroform dosimetry model for male and female F-344 rats (abstract). Toxicologist 14, 43.
6. Brusick, D. J., Ashby, J., de Serres, F. J., Lohman, P. H. M., Matsushima, T., Matter, B. E., Mendelson, M. L., Moore II, D. H., Nesnow, S., and Waters, M. D. (1992). A method for combining and comparing short-term genotoxicity test data (A report from ICPEMC, Committee I). Mutat. Res. 266, 1-6.
7. Bucher, J. R., Portier, C. J., Goodman, J. I., Faustman, E. M., and Lucier, G. W. (1996). National Toxicology Program Studies: Principles of dose selection and applications to mechanistic-based risk assessment. Fundam. Appl. Toxicol. 31, 1-8.
8. Cantor, K. P., Hoover, R., and Hartage, P. (1987). Bladder cancer, drinking water source, and tap water consumption: A case control study. J. Natl. Cancer Soc. 79, 1269-1279.
9. Cantor, K. P., Lynch, C. F., Hildesheim, M., Dosemeci, M., Lubin, J., Alavanja, M., and Craun, G. F. (1998). Drinking water source and chlorination by-products: I. In risk of bladder cancer. Epidemiology 9, 21-28.
10. Clewell III, H. J., and Andersen, M. E. (1985). Risk assessment extrapolations and physiological modeling. Toxicol. Ind. Health 1, 111-131.
11. Clewell, H. J., Gentry, P. R., Barton, H. A., Shipp, A. M., Yager, J. W., and Andersen, M. E. (1998). Requirements for a biologically realistic cancer risk assessment for inorganic arsenic. Int. J. Toxicol. 18, 131-147.
12. Conolly, R. B. (1995). Cancer and noncancer risk assessment: Not so different if you consider mechanisms. Toxicology 102, 179-188.
13. Conolly, R. B., Casanova, M., and Heck, H. d'A. (1997). Formaldehyde dose-response assessments using DNA-protein cross-link and cell replication data. Poster presented at 1997 Society for Risk Analysis Annual Meeting, Washington, DC.
14. Conolly, R.B. and Preston, R.B. (1998). Relative roles of cytolethality and mutagenicity in the carcinogenicity of formaldehyde. Poster presented at 1998 Society for Risk Analysis Annual Meeting, Phoenix.
15. Corley, R. A., Mendrala, A. L., Smith, F. A., Staats, D. A., Gargas, M. L., Conolly, R. B., Andersen, M. E., and Reitz, R. H. (1990). Development of a physiologically based pharmacokinetic model for chloroform. Toxicol. Appl. Pharmacol. 103, 512-527.
16. Cornett, R., Yan, Z., Henderson, G., Stacpoole, P. W., and James, M. O. (1997). Cytosolic biotransformation of dichloroacetic acid (DCA) in the Sprague-Dawley rat (Abstract). Fundam. Appl. Toxicol. (suppl. 36), 318.
17. Counts, J. L., and Goodman, J. I. (1995). Principles underlying dose selection for, and extrapolation from the carcinogen bioassay: Dose influences mechanism. Regul. Toxicol. Pharmacol. 21, 418-421.
18. Cragle, D. L., Shy, C. M., Struba, R. J., and Siff, E. J. (1985). A case-control study of colon cancer and water chlorination in North Carolina. In Water Chlorination: Chemistry, Environmental Impact and Health Effects . R. L. Jolley, R. J. Bull, and W. P. Davis (Eds.), pp. 153-159. Lewis Publishers, Chelsea, MI.
19. Daniel, F. B., DeAngelo, A. B., Stober, J. A., Olson, G. R., and Page, N. P. (1992). Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 19, 159-168.
20. DeAngelo, A. B., Daniel, F. B., Most, B. M., and Olson, G. R. (1996). The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology 114, 207-221.
21. DeAngelo, A. B., Daniel, F. B., Stober, J. A., and Olson, G. R., (1991). The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 16, 337-347.
22. De Biasi, A, Sbraccia, M., Keizer, J., Testai, E., and Vittozzi, L. (1992). The regioselective binding of CHC13 reactive intermediates to microsomal phospholipids. Chem. Biol. Interact. 85, 229-242.
23. de Groot, H., and Noll, T. (1989). Halomethane hepatotoxicity: Induction of lipid peroxidation and inactivation of cytochrome P-450 in rat liver microsomes under low oxygen partial pressure. Toxicol. Appl. Pharmacol. 97, 530-537.
24. DeMarini, D. M., Perry, E., and Shelton, M. L. (1994). Dichloroacetic acid and related compounds: induction of prophage in E.coli and mutagenicity and mutation spectra in Salmonella TA100. Mutagenesis 9, 429-437.
25. Dourson, M. L. (1994). Methodology for establishing oral reference doses (RfDs). In Risk Assessment of Essential Elements (W. Mertz, C. O. Abernathy, and S. S. Olin, Eds.), pp. 51-61. ILSI Press, Washington, DC.
26. Dourson, M. L., Felter, S. P., and Robinson, D. (1996). Evolution of science-based uncertainty factors in noncancer risk assessment. Reg. Toxicol. Pharm. 24, 108-120.
27. Dourson, M. L., Knauf, L. A., and Swartout, J. C. (1992). On reference dose (RfD) and its underlying toxicity database. Toxicol. Ind. Health 8, 171-189.
28. Dourson, M. L., and Stara, J. F. (1983). Regulatory history and experimental support of uncertainty (safety) factors. Regul. Toxicol. Pharmacol. 3, 224-238.
29. Doyle, T. J., Zheng, W., Cerhan, J. R., Hong, C. P., Sellers, T. A., Kushi, L. H., and Folsom, A. R. (1997). The association of drinking water source and chlorination by-products with cancer incidence among postmenopausal women in Iowa: A prospective cohort study. Am. J. Pub. Health 87, 7.
30. Foran, J. A. (1997). Principles for the selection of doses in chronic rodent bioassays. ILSI Risk Science Working Group on Dose Selection. Environ. Health Perspect. 105, 18-20.
31. Freedman, M., Cantor, K. P., Lee, N. L., Chen, L. S., Lei, H. H., Ruhl, C. E., and Wang, S. S. (1997). Bladder cancer and drinking water: A population-based case-control study in Washington County, Maryland (United States). Cancer Causes and Control 8, 738-744.
32. Gargas, M. L., Clewell, H. J. III, and Andersen, M. E. (1990). Gas uptake inhalation techniques and the rates of metabolism of chloromethanes, chloroethanes, and chloroethylenes in the rat. Inhal. Toxicol. 2, 295-319.
33. Gonzalez-Leon, A., and Bull, R. J. (1996). Continuous treatment with dichloroacetate in drinking water alters its metabolism in rats but not in mice (Abstract). Fundam. Appl. Toxicol. 1108(Suppl. 30), 217.
34. Gonzalez-Leon, A., Schultz, I. R., and Bull, R. J. (1997a). Species differences in the toxicokinetics of dichloroacetate and trichloroacetate in F344 rats and B6C3F1 mice after prolonged administration in drinking water. Fundam. Appl. Toxicol. (Abstract) 168(Suppl. 36), 33.
35. Gonzalez-Leon, A., Schultz, I. R., Xu, G., and Bull, R. J. (1997b). Pharmacokinetics and metabolism of dichloroacetate in the F344 rat after prior administration in drinking water. Toxicol. Appl. Pharmacol. 146, 189-195.
36. Green, T. (1983). The metabolic activation of dichloromethane and chlorofluoromethane in a bacterial mutation assay using Salmonella typhimurium. Mutat. Res. 118, 277-288.
37. Health Canada (1999). Supporting Documentation for the Health Assessment of Chloroform as a Priority Substance under the Canadian Environmental Protection Act. Ottawa, Ontario, Canada.
38. Herbert, V., Gardner, A., and Colman, N. (1980). Mutagenicity of dichloroacetate, an ingredient of some formulations of pangamic acid (trade-named "vitamin B15"). Am. J. Clin. Nutr. 33, 1179-1182.
39. Hildesheim, M. E., Cantor, K. P., Lynch, C. F., Dosemeci, M., Lubin, J., Alavanja, M., and Craun, G. F. (1998). Drinking water source and chlorination byproducts: II. Risk of colon and rectal cancers. Epidemiology 9, 29-35.
40. International Agency for Research on Cancer (1995). Monographs on the evaluation of carcinogenic risks to humans, Vol.63: Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. IARC, Lyon, France.
41. International Life Sciences Institute (ILSI, 1997). An evaluation of EPA's "Proposed Guidelines for Carcinogen Risk Assessment" using chloroform and dichloroacetate as case studies: Report of an expert panel. ILSI HESI, Washington, DC.
42. International Programme on Chemical Safety (IPCS) (1994). Environmental health criteria 163: Chloroform. International Programme on Chemical Safety, WHO, Geneva.
43. International Programme on Chemical Safety (IPCS, 1998). Cancer Risk Assessment, 1998 Hannover Workshop Report. World Health Organization, Geneva.
44. King, W. D., and Marrett, L. D. (1996). Case-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada). Cancer Causes Control 7, 596-604.
45. Jorgenson, T. A., Meierhenry, E. F., Rushbrook, C. J., Bull, R. J., and Robinson, M. (1985). Carcinogenicity of chloroform in drinking water to male Osborne-Mendel rats and female B6C3F1 mice. Fundam. Appl. Toxicol. 5, 760-769.
46. Larson, J. L., Wolf, D. C., and Butterworth, B. E. (1994a). Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: Comparison of administration by gavage in corn oil vs. ad libitum in drinking water. Fundam. Appl. Toxicol. 22, 90-102.
47. Larson, J. L., Wolf, D. C. Morgan, K. T., Méry, S., and Butterworth, B. E. (1994b). The toxicity of 1-week exposures to inhaled chloroform in female B6C3F1 mice and male F-344 rats. Fundam. Appl. Toxicol. 22, 431-446.
48. Larson, J. L., Wolf, D. C., and Butterworth, B. E. (1995). Induced regenerative cell proliferation in liver and kidneys of male F-344 rats given chloroform in corn oil by gavage or ad libitum in drinking water. Toxicology 95, 73-86.
49. Leung, H. (1991). Development and utilization of physiologically based pharmacokinetic models for toxicological applications. J. Toxicol. Environ. Health 32, 247-267.
50. Lilly, P. D. (1996). A physiologically based toxicity model of orally administered bromodichloromethane. Submitted Ph.D. thesis, University of North Carolina at Chapel Hill, NC.
51. Lohman, P. H. M., Mendelsohn, M. L., Moore II, D. H., Waters, M. D., Brusick, D. I., Ashby, J., and Lohman W. J. A. (1992). [ICPAEMC report:] A method for comparing and combining short-term genotoxicity test data: The basic system. Mutat. Res. 266, 7-25.
52. Marnett, L. J., Hurd, H. K., Hollstein, M. C., Levin, D. E., Esterbauer, H., and Ames, B. N. (1985). Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. Mutat. Res. 148, 25-34.
53. Matsuda, H., Ose, Y., Nagase, H., Sato, T., Kito, H., and Sumida, K. (1991). Mutagenicity of ozonation and chlorination products from p-hydroxybenzaldehyde. Sci. Total Environ. 103, 141-149.
54. McGeehin, M. A., Reif, J. S., Becher, J. C., and Mangione, E. J. (1993). Case-control study of bladder cancer and water disinfection methods in Colorado. Am. J. Epidemiol. 138, 492-501.
55. Meier, J. R. (1988). Genotoxic activity of organic chemicals in drinking water. Mutat. Res. 196, 211-245.
56. National Research Council (NRC, 1983). Risk Assessment in the Federal Government: Managing the Process. National Academy Press, Washington, DC.
57. National Research Council (NRC, 1994). Science and Judgement in Risk Assessment. National Academy Press, Washington, DC.
58. Page, N., Singh, D. V., Farland, W., Goodman, J. I., Conolly, R. B., Andersen, M. E. Clewell, H. J., Frederick, C. B., Yamasaki, H., and Lucier, G. (1997). Implementation of EPA revised cancer risk assessment guidelines: Incorporation of mechanistic and pharmacokinetic data. Fundam. Appl. Toxicol. 37, 16-3
59. Pegram, R. A., Andersen, M. E., Warren, S. H., Ross, T. M., and Claxton, L. D. (1997). Glutathione S-transferase-mediated mutagenicity of trihalomethanes in Salmonella typhimurium: Contrasting results with bromodichloromethane and chloroform. Toxicol. Appl. Pharmacol. 144, 183-188.
60. Pohl, L. R., Bhooshan, B., Whittaker, N. F., and Krishna, G. (1977). Phosgene: A metabolite of chloroform. Biochem. Biophys. Res. Commun. 79, 684-691.
61. Pohl L. R., and Krishna, G. (1978). Deuterium isotope effect in bioactivation and hepatotoxicity of chloroform. Life Sci. 23, 1067-1072.
62. Renwick, A. G. (1993). Data-derived safety factors for evaluation of food additives and environmental contaminants. Food Addit. Contam. 10, 275-305.
63. Risk Policy Report (1998a). Chloroform controversy raises major science, risk policy stakes. (D. Clarke, Ed.) Inside Washington 5, 18-19.
64. Risk Policy Report (1998b). Chloroform call sparks scientific concerns about EPA risk policies. (S. Gibb, Ed.), Inside Washington 5, 3-7.
65. Sanchez, I. M., and Bull, R. J. (1990). Early induction of reparative hyperplasia in B6C3F1 mice treated with dichloroacetate and trichloroacetate. Toxicology 64, 33-46.
66. Sasaki, Y., and Endo, R. (1978). Mutagenicity of aldehydes in Salmonella. Mutation Res. 54, 251-252.
67. Sayato, Y., Nakamuro, K., and Ueno, H. (1987). Mutagenicity of products formed by ozonation of naphthoresorcinol in aqueous solutions. Mutat. Res. 189, 217-222.
68. Stacpoole, P. W., Henderson, G. N., Yan, Z., Cornett, R., and James, M. O. (1997). Pharmacokinetics, metabolism, and toxicology of dichloroacetate. Drug Metab. Rev. 30, 499-539.
69. Stacpoole, P. W., Moore, G. W., and Kernhauser, D. M. (1979). Toxicity of chronic dichloroacetate. N. Engl. J. Med. 300, 372.
70. Templin, M. V., Larson, J. L. Butterworth, B. E., Jamison, K. C., Leininger, J. R., Mery, S., Morgan, K. T. Wong, B. A., and Wolf, D. C. (1996). A 90-day chloroform inhalation study in F-344 rats: Profile of toxicity and relevance to cancer studies. Fundam. Appl. Toxicol. 32, 109-125.
71. Testai, E., Di Marzio, S., and Vittozzi, L. (1990). Multiple activation of chloroform in hepatic microsomes from uninduced B6C3F1 mice. Toxicol. Appl. Pharmacol. 104, 496-503.
72. Testai, E., and Vittozzi, L. (1986). Biochemical alterations elicited in rat liver microsomes by oxidation and reduction products of chloroform metabolism. Chem. Biol. Interact. 59, 157-171.
73. Thier, R., Taylor, J. B., Pemble, S. E., Humphreys, W. G., Persmark, M., Ketterer, B., and Guengerich F. P. (1993). Expression of mammalian glutathione-S-transferase 5-5 in Salmonella typhimurium TA1535 leads to base-pair mutations upon exposure to halomethanes. Proc. Natl. Acad. Sci. U S A 90, 8576-8580.
74. Tomasi, A., Albano, E., Biasi, F., Slater, T. F., Vannini, V., and Dianzani, M. U. (1985). Activation of chloroform and related trihalomethanes to free radical intermediates in isolated hepatocytes and in the rat in vivo as detected by the ESR-spin trapping technique. Chem. Biol. Interact. 55, 303-316.
75. U.S. Environmental Protection Agency (1986). Guidelines for carcinogen risk assessment. Fed. Reg. 51, 33992-34003.
76. U.S. Environment Protection Agency (1988). Final rule on melamine: toxic chemical release reporting; community right to-know. Fed. Reg. 53, 23128-23133.
77. U.S. Environment Protection Agency (1992). Guidelines for exposure assessment. Fed. Reg. 57, 22888-22938.
78. U.S. Environmental Protection Agency (1994). "Methods for the Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry." U.S. EPA, EPA/600/8-90/066F.
79. U.S. Environmental Protection Agency (1995). EPA risk characterization policy and guidance. Science Policy Council, March 1995, Washington, DC.
80. U.S. Environmental Protection Agency (1996). Proposed guidelines for carcinogen risk assessment: Notice. Fed. Reg. 61, 17960-18011.
81. U.S. Environmental Protection Agency (1998a). National primary drinking water regulations: Disinfectants and disinfection by-products, notice of data availability; proposed rule. Fed. Reg. 63, 15674-15692.
82. U.S. Environmental Protection Agency (1998b). National primary drinking water regulations: disinfectants and disinfection byproducts; final rule. Fed. Reg. 63, 69389-69476.
83. Wolf, C. R., Mansuy, D., Nastainczyk, W., Deutschmann, G., and Ullrich, V. (1977). The reduction of polyhalogenated methanes by liver microsomal cytochrome P-450. Mol. Pharmacol. 13, 698-705.
84. World Health Organization (WHO) (1996). Guidelines for Drinking Water Quality, 2nd ed., Vol.2. WHO, Geneva.
85. Yamaguchi, T., and Nakagawa, K. (1993). Mutagenicity of formation of oxygen radicals by trioses and glyoxal derivatives. Agric. Biol. Chem. 47, 2461-2465.
86. Young, T. B., Wolf, D. A., and Kanarek, M. S. (1987). Case-control study of colon cancer and drinking water trihalomethanes in Wisconsin. Int. J. Epidemiol. 16, 190-197.